Bladder cancer, Kidney cancer, Transitional cell cancer
Results
Phase 2
This trial looked at pazopanib for transitional cell cancer of the urinary tract that either hadn’t gone away or came back after treatment with chemotherapy. The urinary tract includes the:
tube that takes urine from the kidney to the bladder (ureter)
tube that drains urine from the bladder and out of the body (urethra)
Cancer Research UK supported this trial.
Recruitment start: 3 August 2012
Recruitment end: 14 October 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Robert J Jones Prof Thomas Powles
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Glasgow
NHS Greater Glasgow and Clyde
The Orchid Research Tissue Bank
This is Cancer Research UK trial number CRUKE/11/021
Last reviewed: 28 June 2017
CRUK internal database number: 8280
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
